Beauty-Stem Biomedical Launches CD34 Signals at Annual Gala

The biotech company unveiled its flagship anti-aging product at a star-studded event in Los Angeles.

Apr. 6, 2026 at 7:37pm

Got story updates? Submit your updates here. ›

A vibrant, neon-outlined illustration of a human cell or stem cell structure, glowing with energy against a dark background, conceptually representing the innovative anti-aging technology behind Beauty-Stem Biomedical's new product.Beauty-Stem Biomedical's new anti-aging product, CD34 Signals, promises to harness the power of stem cells to combat the effects of aging.Los Angeles Today

Beauty-Stem Biomedical, Inc., a pioneering company in regenerative wellness and anti-aging innovation, officially launched its flagship product, CD34 Signals, at the company's 2nd Annual Gala in Los Angeles. The highly anticipated event brought together industry leaders, investors, and media to celebrate the launch of the new anti-aging technology.

Why it matters

Beauty-Stem Biomedical is at the forefront of the rapidly growing regenerative wellness and anti-aging market, which is projected to reach over $330 billion globally by 2027. The launch of CD34 Signals represents a significant milestone for the company as it aims to disrupt the industry with innovative stem cell-based therapies.

The details

CD34 Signals is Beauty-Stem Biomedical's flagship product, a proprietary stem cell-based treatment designed to promote tissue regeneration and slow the aging process. The launch event in Los Angeles featured keynote speeches, product demonstrations, and networking opportunities for the company's partners and investors.

  • Beauty-Stem Biomedical held its 2nd Annual Gala on April 6, 2026 to unveil CD34 Signals.

The players

Beauty-Stem Biomedical, Inc.

A pioneering company in regenerative wellness and anti-aging innovation, focused on developing stem cell-based therapies and products.

Got photos? Submit your photos here. ›

What’s next

Beauty-Stem Biomedical plans to begin distribution of CD34 Signals through select healthcare providers and retail channels in the coming months, with a goal of making the product widely available by the end of 2026.

The takeaway

The launch of CD34 Signals positions Beauty-Stem Biomedical as a leader in the rapidly growing regenerative wellness and anti-aging market, as the company aims to bring innovative stem cell-based therapies to consumers seeking to slow the aging process and improve their overall health and wellbeing.